Health Decisions hopes Management View will cut monitoring costs

By Gareth Macdonald

- Last updated on GMT

Related tags Contract research organization Clinical trial

US CRO Health Decision says the new “Monitor View” module for its HD360 trial management system makes assessing study site performance an easier and more cost effective process.

The North Carolina contract research organisation (CRO) estimates that site monitoring, including travel and assessment, can account for up to 80 of a trial’s budget, particularly given the growth of multi-country studies.

The module, which is designed to streamline the monitoring process, collects and presents site performance data to sponsors via the web in an approach that, the firm claims, “[produces] faster, more accurate results with fewer wasted resources.”

It also schedules inspections based on the amount of work conducted at a particular site, thereby avoiding arbitrary visits to locations that may not have amassed a significant quantity of data.

Health Decisions COO Rick Farris explained that efficiency was the key motivation for developing the new extension.

For a clinical trial to be truly efficient, every person working on it must have access to the right information, which includes both performance data and meaningful analysis, as quickly as possible​.”

“By granting monitors the ability to continuously refine the trial’s operations within the limits of their role, HD360˚ and our Agile Clinical Development platform allow every study to benefit from efficiency-boosting adaptive techniques with no added risk to data integrity or patient safety.”

He went on to say that Monitor View is already providing benefits for trial monitors, both in day to day operations and overall trial performance.

Sites, investigators and sponsors

The new module is the second extension of the HD360 system after the aptly named clinical investigator monitoring tool “Investigator View”, which was launched earlier this year and has since been upgraded with “sleeker reports” and “search filters.”

The third and final update, scheduled for release in 2010, “Sponsor View” is designed to enhance reporting and data analysis and will, according to head of Heal Decisions IT department Maurice Hagar, complete HD360 as a trial management hub.

“Each study role, investigator site, monitor, sponsor and every function in between, will be equipped with information to more actively contribute to the study’s overall success.

“The end result is an unbroken stream of data handled as efficiently as possible from start-up to database lock and beyond, letting us take advantage of every opportunity to make our sponsors’ programs run faster and more smoothly.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Webinars